Peter Sankey
Impact in
- Oncology top 10%
- COVID-19 and healthcare impacts
- Global Cancer Incidence and Screening
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Screening and Detection
-
- Infection Control and Ventilation
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- COVID-19 and healthcare impacts 2
- Global Cancer Incidence and Screening 1
-
- Prostate Cancer Treatment and Research 4
- Cancer-related cognitive impairment studies 1
- Co-authors
- Christopher McNair (2 shared papers)Elnara Fazio‐Eynullayeva (2 shared papers)Matvey B. Palchuk (2 shared papers)Jack London (2 shared papers)Robert H. Jones (2 shared papers)Debra H. Josephs (4 shared papers)Daniel Poon (2 shared papers)Simon J. Crabb (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)JCO Clinical Cancer Informatics (1 paper)Clinical Cancer Research (1 paper)Drug and Therapeutics Bulletin (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Peter Sankey
7 papers receiving 254 citations
Peers
Comparison fields: 5 of 34
- Oncology 204
- Pulmonary and Respiratory Medicine 42
- Economics and Econometrics 27
- Infectious Diseases 15
- Obstetrics and Gynecology 5
Countries citing papers authored by Peter Sankey
This map shows the geographic impact of Peter Sankey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sankey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sankey more than expected).
Fields of papers citing papers by Peter Sankey
This network shows the impact of papers produced by Peter Sankey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sankey. The network helps show where Peter Sankey may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Sankey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 225 | |
| 2 | 2020 | 13 | |
| 3 | 2024 | 7 | |
| 4 | 2019 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2025 | 0 | |
| 10 | 2020 | 0 |
About Peter Sankey
Peter Sankey is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Hematology, having authored 10 papers that have together received 258 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (2 papers), COVID-19 and healthcare impacts (2 papers), Multiple Myeloma Research and Treatments (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer-related cognitive impairment studies (1 paper) and Global Cancer Incidence and Screening (1 paper). The work is most often cited by research in Oncology (204 citations), Pulmonary and Respiratory Medicine (42 citations), Economics and Econometrics (27 citations), Infectious Diseases (15 citations) and Obstetrics and Gynecology (5 citations). Peter Sankey has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Christopher McNair, Elnara Fazio‐Eynullayeva, Matvey B. Palchuk, Jack London, Robert H. Jones, Debra H. Josephs, Daniel Poon, Simon J. Crabb, Mark Linch and Yien Ning Sophia Wong. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JCO Clinical Cancer Informatics, Clinical Cancer Research and Drug and Therapeutics Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.